Matrix metalloproteinases in the pathology of natural and bioprosthetic cardiac valves

Cardiovascular Pathology

Volumn 5, Issue 6, 1996, Pages 323-332

  Simionescu, Agneta ^a   Simionescu, Dan T ^a   Deac, Radu F P ^a  

^a Department of Biomedical Research   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCURONIDASE; GELATINASE A; GELATINASE B; METALLOPROTEINASE;

ARTICLE; BIOCHEMISTRY; BIOPROSTHESIS; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HEART VALVE; HISTOLOGY; HUMAN; HUMAN TISSUE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

EID: 0030293571     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1054-8807(96)00043-9     Document Type: Article

References (39)

1. 1. Schoen FJ. Interventional and Surgical Cardiovascular Pathology. Toronto: Saunders, 1989;109-119.
2. 2. Roberts WC. Morphologic aspects of cardiac valve dysfunction. Am Heart J 1992;123:1610-1632.
3. 3. Baramova E, Foidart JM. Matrix metalloproteinase family. Cell Biol Int 1995;19:239-242.
4. 4. Docherty JP, O'Connell J, Crabbe T, Angal S, Murphy G. The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseases. Trends Biotech 1992;10:200-207.
5. 5. Emonard H, Grimaud JA. Matrix metalloproteinases: a review. Cell Mol Biol 1990;36:131-153.
6. 6. Schoen FJ. Interventional and Surgical Cardiovascular Pathology. Toronto: Saunders 1989;124-160.
7. 7. Deac RFP, Simionescu D, Deac D. New evolution in mitral physiology and surgery; mitral stentless pericardial valve. Ann Thorac Surg 1995;60:S433-S438.
8. 8. Walley VM, Wolfson AL, Ghadially FN, Silver MN. Non calcific thickening in Ionescu-Shiley cardiac valvular bioprostheses. Mod Pathol 1995;8:121-129.
9. 9. Ishihara T, Ferrans VJ, Jones M, Boyce SW, Roberts WC. Structure of bovine parietal pericardium and of unimplanted Ionescu-Shiley pericardial valvular bioprostheses. J Thorac Cardiovasc Surg 1981;81: 745-757.
10. 10. Walley VM, Keon WJ. Patterns of failure in Ionescu-Shiley bovine pericardial bioprosthetic valves. J Thorac Cardiovasc Surg 1987;93: 925-933.
11. 11. Simionescu D, Simionescu A, Deac R. Detection of remnant proteolytic activities in unimplanted glutaraldehyde-treated bovine pericardium and explanted bioprostheses. J Biomed Mater Res 1993;27: 821-829.
12. 12. Simionescu D, Deac R, Simionescu A. Inhibition of extracellular-matrix degrading proteases in pericardial-derived cardiovascular bioprostheses. J Mater Sci 1994;5:748-751.
13. 13. Simionescu D, Simionescu A, Deac R. Mapping of glutaraldehyde-treated bovine pericardium and tissue selection for bioprosthetic heart valves. J Biomed Mater Res 1993;27:697-704.
14. 14. Schoen FJ. Interventional and Surgical Cardiovascular Pathology. Toronto: Saunders, 1989;370-375.
15. 15. Deac R, Liebhart M, Bradisteanu S, Bratu D. Cardiac valve replacement with pericardial xenograft. In: Bircks W, Ostermeyer J, Schultze HD, eds. Cardiovascular Surgery. Heidelberg: Springer-Verlag, 1981; 640-644.
16. 16. Henkel AW, Bieger SC. Quantification of proteins dissolved in an electrophoresis sample buffer. Anal Biochem 1994;223:329-331.
17. 17. Tyagy SC, Matsubara L, Weber KT. Direct extraction of collagenase activity by zymography in microquantities of rat myocardium and uterus. Clin Biochem 1993;26:191-198.
18. 18. Fishman WH, Springer B, Brunetti R. Application of an improved glucuronidase assay method to the study of human blood beta-glucuronidase. J Biol Chem 1948;173:449-454.
19. 19. Thompson RW, Holmes DR, Mertens RA, et al. Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurisms. J Clin Invest 1995;96:318-326.
20. 20. Brown DL, Hibbs MS, Kearney M, Loushin C, Isner JM. Identification of 92-kD gelatinase in human coronary atherosclerotic lesions: association of active enzyme synthesis with unstable angina. Circulation 1995;91:2125-2131.
21. 21. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994;94:2493-2503.
22. 22. Filip DA, Radu A, Simionescu M. Interstitial cells of the heart valves possess characteristics similar to smooth muscle cells. Circ Res 1986;59:310-320.
23. 23. Simionescu N, Simionescu M. The cardiovascular system. In: Weiss L, Ed. Histology; Cell and Tissue Biology. New York, Elsevier, 1977; 424.
24. 24. Newman KM, Malon AM, Shin RD, Scholes JV, Ramey WG, Tilson MD. Matrix metalloproteinases in abdominal aortic aneurysm: characterization, purification and their possible sources. Conn Tiss Res 1994;30:265-276.
25. 25. Fini ME, Girard MT, Matsubara M, Bertlett JD. Unique regulation of the matrix metalloproteinase, gelatinase B. Invest Ophthal Visual Sci 1995;36:622-632.
26. 26. Bergmann U, Tuutilla A, Stetler-Stevenson WG, Tryggvason K. Autolytic activation of recombinant human 72 kilodalton type IV collagenase. Biochem 1995;34:2819-2825.
27. 27. Bullen EC, Longaker MT, Updike DL, et al. Tissue inhibitor of metalloproteinase-1 is decreased and activated gelatinases are increased in chronic wounds. J Invest Dermatol 1995;104:236-240.
28. 28. Ries C, Petrides PE. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol Chem Hoppe-Seyler 1995;376:345-355.
29. 29. Moutsiakis D, Mancuso P, Krutzsch H, Stetler-Stevenson WG, Zucker S. Characterisation of metalloproteinases and tissue inhibitors of metalloproteinases in human plasma. Conn Tiss Res 1992;28:213-230.
30. 30. Manicourt DH, Fujimoto N, Obata K, Thonar EJMA. Serum levels of collagenase, stromelysin-1 and TIMP-1. Arthritis and Rheum 1994;37: 1774-1783.
31. 31. Sarret Y, Woodley DT, Goldberg GS, Kronberger A, Wynn KC. Constitutive secretion of a 92-kDa keratinocyte-derived type IV collagenase is enhanced by type I collagen and decreased by type IV collagen matrices. J Invest Dermatol 1992;99:836-841.
32. 32. Salvesen G, Nagase H. Inhibition of proteolytic enzymes. In: Beynon RJ, Bond JS, eds. Proteolytic enzymes: a practical approach. Oxford: IRL Press, 1989;93-98.
33. 33. Alarcon GS, Mikhail IS. Antimicrobials in the treatment of rheumatoid arthritis and other arthritides: a clinical perspective. Am J Med Sci 1994;308:201-209.
34. 34. Vincenti MP, Clark IM, Brinckerhoff CE. Using inhibitors of metalloproteinases to treat arthritis. Arthritis and Rheum 1994;37:1115-1126.
35. 35. Sharma AK, Mauer SM, Kim Y, Michael AF. Altered expression of matrix metalloproteinase-2, TIMP, and TIMP-2 in obstructive nephropathy. J Lab Clin Med 1995;125:754-761.
36. 36. Bellon JM, Bujan J, Contreras L, Hernando A. Integration of biomaterials implanted into abdominal wall: process of scar formation and macrophage response. Biomaterials 1995;16:381-387.
37. 37. Ferrans VJ, Spray TL, Billingham ME, Roberts WC. Structural changes in glutaraldehyde-treated porcine heterografts used as substitute cardiac valves. Am J Cardiol 1989;41:1159-1184.
38. 38. Dahm M, Husman M, Mayer E, Prufer D, Groh E, Oelert H. Relevance of immunologic reactions for tissue failure of bioprosthetic heart valves. Ann Thorac Surg 1995;60:S348-S352.
39. 39. Moczar M, Mazzucotelli JP, Bertrand P, Ginat M, Leandri J, Loisance D. Deterioration of bioprosthetic heart valves. ASAIO J 1994;40: M697-M701.